Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20929 / DOSAGE - SUSPENSION;INHALATION - 1MG/2ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUDESONIDE(UNII: Q3OKS62Q6X) (BUDESONIDE - UNII:Q3OKS62Q6X) | BUDESONIDE | 0.5mg in 2 |
Inactive Ingredients
| Ingredient Name | Cardinal Health | A-S Medication Solutions | American Health Packaging | Cipla USA Inc. | Exelan Pharmaceuticals, Inc. | NorthStar RxLLC | Preferred Pharmaceuticals Inc. | Teva Pharmaceuticals USA, Inc. |
|---|---|---|---|---|---|---|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | ||||||||
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | ||||||||
| EDETATE DISODIUM(7FLD91C86K) | ||||||||
| POLYSORBATE 80(6OZP39ZG8H) | ||||||||
| SODIUM CHLORIDE(451W47IQ8X) | ||||||||
| SODIUM CITRATE(1Q73Q2JULR) | ||||||||
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | ||||||||
| TRISODIUM CITRATE DIHYDRATE(B22547B95K) | ||||||||
| WATER(059QF0KO0R) |
